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Abstract
Background: Surveillance of severe acute respiratory infections (SARI) in sentinel hospitals is recommended to
estimate the burden of severe influenza-cases. Therefore, we monitored patients admitted with respiratory
infections (RI) in 9 Berlin hospitals from 7.12.2009 to 12.12.2010 according to different case definitions (CD) and
determined the proportion of cases with influenza A(H1N1)pdm09 (pH1N1). We compared the sensitivity and
specificity of CD for capturing pandemic pH1N1 cases.
Methods: We established an RI-surveillance restricted to adults aged ≤ 65 years within the framework of a pH1N1
vaccine effectiveness study, which required active identification of RI-cases. The hospital information-system was
screened daily for newly admitted RI-patients. Nasopharyngeal swabs from consenting patients were tested by PCR
for influenza-virus subtypes. Four clinical CD were compared in terms of capturing pH1N1-positives among
hospitalized RI-patients by applying sensitivity and specificity analyses. The broadest case definition (CD1) was used
for inclusion of RI-cases; the narrowest case definition (CD4) was identical to the SARI case definition
recommended by ECDC/WHO.
Results: Over the study period, we identified 1,025 RI-cases, of which 283 (28%) met the ECDC/WHO SARI case
definition. The percentage of SARI-cases among internal medicine admissions decreased from 3.2% (calendar-week
50-2009) to 0.2% (week 25-2010). Of 354 patients tested by PCR, 20 (6%) were pH1N1-positive. Two case definitions
narrower than CD1 but -in contrast to SARI- not requiring shortness of breath yielded the largest areas under the
Receiver-Operator-Curve. Heterogeneity of proportions of patients admitted with RI between hospitals was
significant.
Conclusions: Comprehensive surveillance of RI cases was feasible in a network of community hospitals. In most
settings, several hospitals should be included to ensure representativeness. Although misclassification resulting
from failure to obtain symptoms in the hospital information-system cannot be ruled out, a high proportion of
hospitalized PCR-positive pH1N1-patients (45%) did not fulfil the SARI case-definition that included shortness of
breath or difficulty breathing. Thus, to assess influenza-related disease burden in hospitals, broader, alternative case
definitions should be considered.
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On June 11, 2009, the World Health Organization
(WHO) declared an influenza pandemic caused by influ-
enza A(H1N1)pdm09 (referred to as pH1N1 in the fol-
lowing). After only low levels of pH1N1 activity during
spring and summer 2009, Germany registered an
increase in the number of cases starting in calendar
week 42 (October) 2009. The ensuing influenza wave
peaked in week 46 (November) 2009 and caused almost
250 reported deaths [1] and an estimated 2.9 (95% CI:
2.5-3.4) million outpatient consultations [2].
Influenza is an acute viral disease of the respiratory
tract. The majority of previously healthy individuals
recover within 2 weeks. However, influenza can present
as serious disease, for instance, as primary pneumonia,
or lead to exacerbation of pre-existing cardiovascular
and pulmonary disease. The very young, the elderly and
patients with underlying illnesses are most at risk of
developing these potentially life-threatening complica-
tions [3]. However, severe disease due to pH1N1 has
also been observed in older children and young adults
[4]. Estimates of pH1N1 case fatality range from 0.005%
[5] in New Zealand, over 0.05% [6] in the United States,
to 1.7% in Peru [7].
WHO and the European Centre for Disease Preven-
tion and Control (ECDC) recommend hospital-based
surveillance of severe acute respiratory infections (SARI)
as a tool to monitor severe disease caused by influenza
[8]. This can complement surveillance of outpatient
monitoring of influenza like illness (ILI) or acute
respiratory illness (ARI) to cover the full spectrum of
influenza-related disease. In addition, trends in the
severity of a pandemic might be detected early, and risk
factors for severe disease may be identified [8,9]. A
number of countries within the WHO European region
have recently established SARI surveillance of different
scope and profile [10].
In Germany, systems to estimate the burden of severe
disease due to influenza were not well established dur-
ing the 2009 influenza pandemic. One such system, the
pandemic hospital based surveillance (PIKS), was imple-
mented in week 49 in 2009 by the Robert Koch Institute
[11] to collect data on patients admitted to hospitals due
to laboratory confirmed influenza, their proportion
among all admitted patients, influenza cases admitted to
intensive care units (ICU) as well as fatal cases. How-
ever, syndromic SARI surveillance was not routinely
performed.
In the winter of 2009/10 a hospital-based pandemic
influenza vaccine effectiveness study was launched. This
required active case finding of all admitted patients with
an acute respiratory infection to identify potential influ-
enza cases and opened a window of opportunity to
monitor the number of cases admitted with respiratory
infections (RI). Our objective was to monitor the epide-
miology of cases admitted with RI over time in partici-
p a t i n gh o s p i t a l sa st h ep r o p o r t i o no fa l li n t e r n a l
medicine and ICU admissions and to determine the pro-
portion of cases with pH1N1. We applied different case
definitions (CD), including SARI, to patients admitted
with RI and tested their sensitivity and specificity for
detecting pH1N1 positive patients.
Methods
Study period
We collected data for the period from December 7,
2009 to December 12, 2010. We divided the study per-
iod into two segments according to the level of influ-
enza activity detected in Berlin. Of all notified influenza
cases in Berlin, 95% were reported before week 2 in
2010, which coincided with a decline of the German-
wide consultation index of respiratory infections to
background levels [12].
Elevated activity of respiratory infections was reported
in week 49 (early December) 2010 and a week later,
29% of sentinel laboratory specimen sent to the Influ-
e n z aR e f e r e n c eC e n t r ew e r ep o s i t i v ef o ri n f l u e n z a ,i n d i -
cating the beginning of influenza circulation in the
2010/2011 season at the end of our study period [13].
Thus, we defined study period 1 as time with signifi-
cant influenza circulation which lasted from December
7, 2009 to January 10, 2010, followed by study period 2
with low or absent circulation during the spring, sum-
mer, and autumn months of 2010 (January 11, 2010 to
December 12, 2010).
Data collection
The hospital information-system (ORBIS
©) of 9 commu-
nity hospitals of the Vivantes Network for Health was
screened daily for newly admitted patients. These 9 hos-
pitals serve ~30% of the Berlin population (3.4 million
inhabitants) [14]. A study team comprised of 9 study
nurses and additional 12 study assistants was assigned
to these locations, where they accessed electronic admis-
sion entries to identify all patients admitted with acute
respiratory infections to internal medicine and ICU
wards. Electronic charts were checked for symptoms ful-
filling the broadest case definition (CD) for RI (defined
as CD1, see below) as outlined below and for date of
disease onset. In cases of incomplete documentation on
admission, the study team contacted nursing staff on
the respective wards to obtain this information. More-
over, the study team extracted information on age, sex,
place of residence, admission to ICU, and length of hos-
pital stay. Collected data were entered into an excel
spreadsheet at the hospital and transmitted to the study
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data from all 9 hospitals were merged and analyzed.
The Vivantes hospital administration contributed
weekly data on the aggregated numbers of all patients
admitted to the hospital network in the respective peri-
ods, with separate information on admissions to internal
medicine wards and ICU.
The study population was confined to patients aged 18
to 65 years, since persons older than 65 years were not
included in the vaccine effectiveness study. The study
protocol was approved by the Ethics Committee of the
Charité- University Medicine Berlin.
Case definitions
We applied a broad case definition (CD1) for all hospi-
talized RI to enable retrospective evaluation of the sensi-
tivity and specificity of more specific (narrower) case
definitions and to capture as many pH1N1-positive
cases as possible (Figure 1). CD1 thus also included
patients who did not fulfil some or all of the specific
clinical criteria of an RI so long as an RI was documen-
ted in the chart by a physician as the suspected diagno-
sis. CD4 was the narrowest case definition and was
identical to the SARI case definition as suggested by
ECDC [15] and WHO [8] in 2009. In addition, we tested
sensitivity and specificity of two further case definitions
in terms of capturing the highest proportion of pH1N1-
positives among RI-patients referred to as CD2 and
CD3 (Figure 1). CD2 included only those CD1 patients
who fulfilled the specified clinical criteria and excluded
those CD1 patients based only on a suspected diagnosis
of RI. CD3 was identical to the WHO case definition for
influenza like illness (ILI) [8], originally developed for
the surveillance of influenza in outpatients (WHO
EURO changed the ILI case definition in 2011 [16] by
dropping sore throat and altering the definition of fever)
(Figure 1).
Informed consent for nasopharyngeal swabbing was
sought from all RI patients unless exclusion criteria as
applied in the vaccine effectiveness study were present
(living in a nursing home, not able to give informed
consent, insufficient communication skills, contraindica-
tion for influenza vaccination). All consenting patients
received a nasal and throat swab (Mastaswab; MAST
Diagnostica, Reinfeld, Germany) to obtain material for
real-time polymerase chain reaction (PCR) testing at the
Reference Centre for Influenza. In a few patients
admitted to ICU, material was collected from broncho-
alveolar lavage fluids. PCR was performed as described
previously, targeting the M gene for universal detection
of influenza A viruses as well as the HA and NA genes
for further subtyping including the specific detection of
pH1N1 viruses [17]. This procedure was extensively
validated. The limit of detection (95% detection prob-
ability) was determined at ~ 6 genome equivalents per
reaction indicating a high sensitivity. All PCR assays
used showed 100% specificity with no cross-reactivities
observed with other respiratory viruses or bacteria [17].
From April 2010 onwards, we continued to register
cases from all participating hospitals, but influenza diag-
nosis was offered only to patients from 4 hospitals cov-
ering roughly 13% of Berlin’s population, resulting in a
lower proportion of swabbed patients.
Statistical methods
We calculated proportions of patients fulfilling the
respective case definitions in relation to the overall
number of patients admitted to internal medicine wards
and ICU of the 9 hospitals. To compare medians and
proportions, we used the Kruskal-Wallis and chi-square
test, respectively. The Breslow-Day test was used to
assess homogeneity between strata. As measures of asso-
ciation we calculated relative risks (RR) as well as odds
ratios (OR) and their 95% confidence intervals (CI) by
univariable exact logistic regression. To evaluate trends
over time we applied Poisson regression and calculated
incidence rate ratios (IRR) and 95% CI of the mean. As
Figure 1 Flowchart of case definitions (CD) for hospitalized
respiratory infections. To be included as a case in the hospital-
based surveillance of acute respiratory infections in Berlin, 2009/10,
patients had to fulfil criteria of the broadest case definition (CD1).
All CD1 who did not meet the CD4 (SARI) criteria were classified as
CD1b. CD2 and CD3 fulfilled clinical criteria only and excluded those
where clinical criteria were not fully met but a physician’s
(suspected) diagnosis of RI in the chart led to inclusion. The smallest
subsample of CD1 were cases fulfilling CD4 criteria (SARI as defined
by ECDC/WHO).
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tions we utilized the area under the receiver operator
curves (ROC) and 95% CI (asymptotic normal) of the
area under the curve (AUC); we compared AUC with
chi-square tests. Cases testing negative were only
included as such if the nasopharyngeal swab was taken
within 7 days of symptom onset. A sensitivity analysis
was performed using a swabbing interval of 4 days. Data
analysis was performed with Stata
©, version 11.
Results
Number of cases according to case definition and severity
Overall, we identified 1,025 patients fulfilling the broad
CD1 definition (Table 1). Of these, 283 (28%) fulfilled
CD4 criteria. The remaining 742 (72%) cases were clas-
sified as CD1b. Case definition criteria for CD2 were
met by 63% (n = 648) and for CD3 by 53% (n = 539).
We tested 354 (35%) patients for influenza virus infec-
tion. From calendar week 50/2009 to 14/2010, 291 ARI
patients were identified in the 9 participating hospitals,
of whom 141 (48%) agreed to swabbing. From calendar
week 15/2010 to 49/2010, 734 ARI patients were ascer-
tained, of whom 365 (50%) were from the 4 hospitals in
which testing continued to be offered. Of these, 196
(54%) agreed to provide a nasopharyngeal swab. Reasons
for refusal were not systematically documented, but
there was no significant difference in age (p =0 . 3 )o r
gender distribution (p = 0.2) between those tested or
not. In study period 1, 16 of 56 cases with test results
available (29%) tested pH1N1-positive versus 4 of 286
(1%) in period 2 (Table 2). Overall, CD4 patients were
more likely to give informed consent for nasopharyngeal
swabbing than CD1b patients (RR = 1.9, 95%CI: 1.60-
2.21). The proportion of pH1N1-positives did not differ
significantly between those CD4 and CD1b cases (p =
0.3) that were tested, neither during period 1 (32% vs.
25%, p = 0.5) nor period 2 (2% vs. 1%, p = 0.7).
A higher proportion of both CD1 cases and pH1N1-
positive patients was male (Table 1). Among CD4 cases
men were older than women (p =0 . 0 4 ) ,b u tt h e r ew a s
no statistically significant difference between the age of
men and women fulfilling the CD1 or the CD1b criteria
(p = 0.7). The median age of CD4 patients was lower
than that of CD1b patients (p = 0.05). Exact logistic
regression, however, did not reveal a dose-response rela-
tionship between years of age and odds of fulfilling the
CD4 definition (p =0 . 2 ) .M e d i a na g eo fp H 1 N 1 - p o s i -
tives was lower than in negatives but this was not statis-
tically significant (p = 0.2).
Of the 20 pH1N1- positive cases, 55% were classified
as CD4. Only four pH1N1-positive cases (20%) were
admitted to ICU, of which 3 (75%) were classified as
CD4. None of the 20 pH1N1-positive cases died, but
pH1N1-status was positively associated with ICU-admis-
sion, although this was not statistically significant (p =
0.09). Neither requiring mechanical ventilation (p =0 . 8 )
nor length of hospital stay (p = 0.6, Table 1) showed an
association with pH1N1-status. The risk of ICU-admis-
sion (RR = 1.3, 95%CI: 0.95-1.93) and of requiring
mechanical ventilation (RR = 1.3, 95%CI: 0.69-2.41) was
similar for CD1b and CD4 cases, but median duration
of hospital stay was longer for CD4 than CD1b cases (p
= 0.03). Death during hospital admission occurred in 2%
of CD4 and 4% of CD1b cases (p =0 . 1 3 ) ,b u td a t ao n
patient outcome was missing in 23% of all included
cases. The proportion of cases with missing patient out-
come data did not differ by pH1N1-status, admission to
ICU or CD4 versus CD1 (all p-values > 0.1).
The likelihood of hospitalized RI-patients fulfilling cri-
t e r i af o rt h en a r r o w e s tc a s ed e f i n i t i o n( C D 4 )w a s1 . 3
times higher (95%CI: 1.01-1.75) in study period 1 than
period 2 (35% versus 27%). In addition, CD1-cases had a
RR of 1.7 (95%CI: 1.07-2.62) for admission to ICU and
of 2.6 (95%CI: 1.31-5.04) for requiring mechanical venti-
lation during period 1 compared to period 2.
Overall, 185 of 353 (52%) influenza tests were per-
formed more than 4 days after onset of disease and 80
of 353 (23%) more than 7 days. During study period 1,
none of the 16 pH1N1-positive cases was swabbed > 7
days after symptom onset versus 11 of 40 (28%)
pH1N1-negatives (OR = 0.13; 95%CI: 0-0.85; p =0 . 0 3 ) .
Four (25%) pH1N1-positive cases, but 24 of 40 (60%)
Table 1 Patients with respiratory infections according to case definition and pH1N1 status, demographic and clinical
characteristics, hospital-based surveillance of acute respiratory infections, Berlin 2009/10
Cases Definition
(number of cases)
%
male
Median
age,
females*
Median
age,
males
% requiring
ICU treatment
% requiring
mechanical
ventilation
% pH1N1 positive
among tested
Duration of
hospital stay
(median)
Case
fatality
CD1 (n = 1,025) 61%* 49 y 51 y 12% 6% 6% 6 days 4%
CD1b (n = 742) 62%* 50 y 51 y 11% 5% 4% 6 days 4%
CD4 (n = 283) 57%* 45 y 50 y* 14% 7% 7% 7 days 2%
pH1N1-positive (n
= 20)
65% 42 y 46 y 20% 7% 100% 6 days 0%
* statistically significant (p < 0.05) when compared to female cases
See text and Figure 1 for explanation of CD1, 1b and 4
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after symptom onset.
Differences between hospitals
Absolute and relative numbers of patients admitted due
t oR Iv a r i e db ys t u d yl o c a t i o n .O v e rt h ee n t i r es t u d y
period, the mean proportion of CD1-cases among inter-
nal medical ward admissions was 4.9% and ranged from
3.3% to 8.4% between hospitals (p < 0.01). The propor-
tion of CD4 cases among all respiratory infections was
28% overall and ranged from 19% to 44% in participat-
ing hospitals (p < 0.01). These results indicated hetero-
geneity among study locations. Neither the percentage
of pH1N1 positives nor the gender distribution differed
significantly by hospital among those tested (p =0 . 2 ) ,
nor did the gender distribution (p =0 . 1 2 ) .H o w e v e r ,
median age of included RI-patients ranged from 45 to
56 years by study location (p < 0.01).
Development over time
We calculated the weekly incidence of all CD1-cases,
CD1b cases, and CD4 cases as a percentage of all admis-
sions to internal medicine wards and of all CD1-cases
admitted to ICU as a percentage of all ICU admissions
(Figure 2 and 3, Table 3). All incidences showed statisti-
cally significant changes over time. Admission of CD1b
cases exhibited a biphasic pattern with a decline from
5.1% in week 50/2009 to a minimum of 1.4% in week
29/2010, with a weekly IRR of 0.99 (95%CI: 0.98-1.00).
Thereafter, the IRR was 1.02 (95%CI: 1.00-1.03) per
week until the end of the study period with a maximum
of 5.6% in week 41 in 2010. We observed a similar pat-
tern for CD4 cases with an IRR of 0.96 (95%CI: 0.94-
0.98) per week to a minimum of 0.2% in week 25 in
2010; followed by a weekly IRR of 1.03 (95%CI: 1.00-
1.06). In contrast, the incidence of all cases among ICU
admissions decreased over the entire study period with
an IRR of 0.98 per week (95%CI: 0.97-0.99).
Sensitivity and specificity of case definitions
The sensitivity and specificity of the case definitions
applied to all included patients using results of PCR testing
as the gold standard are shown in Table 4 both for the
entire study period and separately for study period 1 with
significant influenza virus circulation. The highest sensitiv-
ity was found for CD2; the highest specificity for CD4.
The area under the ROC curve was largest for CD2 in
study period 1 and for CD3 during the entire study period,
although not statistically significantly larger than for CD4
(p > 0.1) (Table 4, Figure 4). ROC areas increased only
minimally if a maximal swabbing interval of 4 instead of 7
days was applied to ascertain pH1N1 negatives.
Discussion
The implementation of a surveillance system monitoring
respiratory diseases at 9 Berlin hospitals initially in the
Table 2 Absolute and relative number of patients tested positive for pH1N1 by case definition and study period,
hospital-based surveillance of acute respiratory infections, Berlin, 2009/10
No. tested for influenza (%) No. testing positive for influenza* (%)
CD1 Period 1 60/110 (55%) 16 (29%)
Period 2 294/915 (32%) 4 (1%)
Total 354/1,025 (35%) 20 (6%)
CD1b Period 1 32/71 (45%) 7 (25%)
Period 2 174/671 (26%) 2 (1%)
Total 206/742 (28%) 9 (5%)
CD4 Period 1 28/39 (72%) 9 (32%)
Period 2 120/244 (49%) 2 (2%)
Total 148/283 (52%) 11 (8%)
*Patients with missing PCR results excluded
Figure 2 Incidence of hospitalized respiratory infections
fulfilling criteria for CD1b and CD4 as a percentage of internal
medicine ward admissions in the study hospitals per calendar
week. Weekly incidences are shown together with predicted
incidences and 95%CI according to Poisson regression. All pH1N1
cases notified in Berlin through the national routine surveillance
system, 2009-2010 are shown for comparison.
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was feasible and delivered important insights into the
distribution of cases over time and according to differ-
ent CD. A large proportion of pH1N1 positives was not
captured by the SARI case definition as recommended
by WHO and ECDC (CD4), with alternative case defini-
tions having a better combination of sensitivity and spe-
cificity (Table 4).
As expected, the incidence of both CD1b and CD4-
cases was subject to the influence of seasonality. The
proportion of cases fulfilling the narrowest CD4 defini-
tion was highest during study period 1 (winter), a period
with substantial influenza virus circulation, and signifi-
cantly lower thereafter. This was also reflected in the
higher proportion of RI patients admitted to ICU during
period 1. These findings are in keeping with a seasonal
distribution of RI as described previously [18-20]. Our
results suggest that the spectrum of pathogens that cir-
culate during winter causes a higher proportion of
severe cases than the pathogen mix prevailing in spring
and summer. Besides influenza, many respiratory
pathogens exhibit seasonal patterns with peaks during
the winter, e.g. adeno- or coronavirus infections [21],
but our data cannot provide insight as to which indivi-
dual pathogens might cause increased morbidity. In our
study almost a third of all RI-patients was positive for
influenza during study period 1, and other studies have
shown that influenza viruses are among the most com-
mon pathogens leading to hospitalization [21-23] for
respiratory disease or cardio-respiratory failure in the
winter season [24]. Nonetheless, a significant proportion
of respiratory disease is apparently caused by other
pathogens; even if possible underestimation of the pro-
portion of influenza due to late swabbing in our study is
taken into account.
We found that 20% of all hospitalized pH1N1-positive
patients required ICU treatment, a number within the
range of previously reported figures for pH1N1 illness
[25,26]. The higher risk of admission to ICU, mechani-
cal ventilation and death in CD4 compared to CD1b
cases was not statistically significant; this may have been
due to insufficient power. Hospital stay was significantly
longer in CD4 than in CD1b-cases.
The definition of CD4 (identical to the WHO/ECDC
SARI case definition) captured only 55% of all hospita-
lized pH1N1-positive cases, and 75% of the pH1N1-
cases requiring ICU management. Although a higher
proportion of CD4 than CD1b-cases was pH1N1-posi-
tive, this difference was not statistically significant in
either study period. Thus, we compared sensitivity and
specificity of different case definitions to explore the
ability of varying combinations of symptoms to capture
PCR-confirmed pH1N1-influenza (gold standard) within
our study population of hospitalized RI-patients. CD2,
which permitted other systemic symptoms as an alterna-
tive to fever and did not require shortness of breath
(SOB), had the highest sensitivity. The sensitivity of
CD3, which differed from CD2 only in the strict
requirement for fever, was only slightly lower. CD4
(SARI) had the lowest sensitivity. The trade-off for high
sensitivity was a low specificity, which applied in reverse
order to the tested case definitions. By comparing the
areas under the ROC curves we took both measures
-sensitivity and specificity- into account and found
Figure 3 Incidence of respiratory infections fulfilling criteria for
CD1 admitted to intensive care units (ICU) as a percentage of
all admissions to ICU per calendar week. Weekly incidences are
shown together with predicted incidences and 95%CI according to
Poisson regression. All pH1N1 cases notified in Berlin through the
national routine surveillance system, 2009-2010 are shown for
comparison.
Table 3 Minimum and maximum weekly incidence of respiratory infections as a proportion of internal medicine
admissions and intensive care unit (ICU) admissions, respectively, according to case definition (CD), hospital-based
surveillance of acute respiratory infections, Berlin, 2009/10
Case definition Maximum Week Minimum Week
CD1 among internal medicine admissions 8.3% 50/2009 2.0% 27/2010
CD1b among internal medicine admissions 5.6% 41/2010 1.4% 29/2010
CD4 among internal medicine admissions 3.2% 50/2009 0.2% 25/2010
CD1 cases among ICU-admissions 10.0% 51/2009 0% repeatedly
See text and Figure 1 for explanation of CD1, 1b and 4
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CD3, at least during the period with significant influenza
circulation. However, although the area under the ROC
was highest for CD4, the difference to CD2 and CD3
was not statistically significant, likely due to overall low
case numbers related to the rather late start of our
study towards the end of the pandemic wave. The opti-
mal syndromic case definition for respiratory infections
to monitor severe (hospitalized) influenza cases has
been subject to repeated discussions as, for instance, the
2011 update to the ILI (CD3) case definition by WHO
Europe highlights: sore throat as a symptom was
dropped and a history of fever as an additional qualify-
ing symptom added [16]. We were not able to assess the
latter case definition as information on the presence of
sore throat was not documented separately from cough
in our study. However, our findings suggest that the
broader case definitions offer advantages for surveillance
of hospitalized influenza cases over the current SARI
case definition as suggested by WHO/ECDC.
Hospitals showed a significant heterogeneity with
respect to the proportions of patients admitted with RI.
This suggests multiple study sites should be carefully
selected to ensure representative surveillance of respira-
tory disease. Since we were interested in the trend of RI
on the level of Berlin’s population rather than single
hospitals we did not stratify by hospital location.
Our study had some important limitations. The link to
the vaccine effectiveness study led to a rather late start
of our hospital-based surveillance, 2-3 weeks after the
peak of the pH1N1-pandemic in Berlin and just a few
weeks before it subsided. This resulted in the inclusion
of a rather small number of pH1N1-positive patients.
More comprehensive results would also have been pos-
sible if children and patients older than 65 years had
been included in the study. Furthermore, the study
e n d e dj u s ta tt h es t a r to ft h e2 0 1 0 / 2 0 1 1i n f l u e n z as e a -
son. Nonetheless, conduction of SARI-surveillance was
found to be feasible in the framework of a hospital-
based vaccine effectiveness study and can be considered
in future pandemic situations if early implementation is
Table 4 Comparison of case definitions (CD) for hospitalized respiratory infections (RI) according to their ability to
capture pH1N1-positive cases
Case definition Cases from entire study period Cases from study period 1
Sensitivity Specificity Area under ROC
(95% CI)
Sensitivity Specificity Area under ROC
(95% CI)
Swabbing interval ≤ 4 days CD4 55% 59% 0.57
(0.45-0.69)
56% 63% 0.59
(0.42-0.77)
CD2 95% 26% 0.60
(0.54-0.66)
100% 44% 0.72
(0.59-0.84)
CD3 90% 41% 0.65
(0.57-0.73)
94% 44% 0.69
(0.55-0.83)
Swabbing interval ≤ 7 days CD4 55% 57% 0.56
(0.45-0.68)
56% 59% 0.57
(0.42-0.73)
CD2 95% 22% 0.59
(0.53-0.64)
100% 38% 0.69
(0.60-0.78)
CD3 90% 35% 0.63
(0.55-0.70)
94% 41% 0.68
(0.57-0.79)
Sensitivity, specificity, area under the receiver operator curve (ROC), percentage of pH1N1-positives captured for study period 1 (significant influenza virus
circulation in Berlin) and the entire study period (gold standard: PCR confirmation of pH1N1 infections)
*Cases testing negative were only included as pH1N1-negative if the interval from symptom onset to swabbing was ≤ 4 days or ≤ 7 days, respectively. Highest
ROC area in bold.
Figure 4 Receiver Operator Curve (ROC) comparing the
capability of different case definitions (CD) for hospitalized
respiratory infections (RI) to capture cases of influenza A/H1N1
2009 (pH1N1). Areas under the ROC curve for CD2, CD3 and CD4
using pH1N1 PCR results as the gold standard for the overall study
period (left) and the period with significant pH1N1 in Berlin (right).
Data based on cases of respiratory infections hospitalized in the
participating hospitals and tested for influenza, Berlin, December
2009 to December 2010. pH1N1 negative cases included only if
period between symptom onset and nasopharyngeal swab ≤ 7
days.
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Page 7 of 9possible. At least in our setting, the presence of trained
study nurses was essential for the success of SARI-sur-
veillance due to the extra work required to extract rele-
vant information from the hospital information-system.
Almost a quarter (23%) of nasal and throat swabs was
taken more than 7 days after symptom onset. This pro-
portion differed by pH1N1-status: 5% among pH1N1-
positives versus 24% among negatives (p =0 . 0 5 2 ) ,s u g -
gesting potential misclassification of pH1N1-positives as
negative. However, other studies reported shedding of
influenza virus for 6 to 9 days and, moreover, that shed-
ding in hospitalized patients and with underlying illness
a p p e a r st ob el o n g e rt h a ni nh o u s e h o l d s[ 2 7 - 3 2 ] .I n
a d d i t i o n ,w ec a n n o tr u l eo ut misclassification from
inability to obtain or document symptoms in the hospi-
tal information-system. This could also be an explana-
tion for the lower sensitivity of the CD4 case definition.
Clinical information on underlying disease, which might
serve to explain gender differences in regards of admis-
sion to ICU, was only available for patients included in
the vaccine effectiveness study (results not shown), but
was not available for all patients in the SARI-surveil-
lance. Finally, our study was confined to one large city
and is therefore not necessarily representative for other
populations.
Conclusions
Overall, experience with SARI-surveillance is scarce and
urgently needed to establish the best practise of moni-
toring disease burden due to severe influenza. Although
our surveillance began after the peak of the pandemic,
our results permitted the depiction of decreasing influ-
enza activity at the end of the pandemic wave. Our
study added valuable insights, such as into the overall
burden of RI patients requiring hospitalization, ICU
admission and mechanical ventilation in periods with
and without influenza virus circulation. In addition, our
ROC comparison suggested that slightly broader case
definitions than the WHO/ECDC SARI definition can
capture a higher proportion of pH1N1 positive cases
a n dm i g h tt h e r e f o r eb em o r ea p p r o p r i a t ef o rs u r v e i l -
lance of hospitalized influenza during epidemic waves or
a pandemic.
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